These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1367 related items for PubMed ID: 22945360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.
    Guo XH.
    Curr Med Res Opin; 2016; 32(1):61-76. PubMed ID: 26439329
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy.
    Derosa G, Maffioli P.
    Curr Clin Pharmacol; 2012 Aug; 7(3):214-28. PubMed ID: 22432846
    [Abstract] [Full Text] [Related]

  • 8. [Impact of anti-diabetic therapy based on glucagon-like peptide-1 receptor agonists on the cardiovascular risk of patients with type 2 diabetes mellitus].
    Camafort-Babkowski M.
    Med Clin (Barc); 2013 Aug 17; 141(4):167-74. PubMed ID: 23332622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emerging GLP-1 receptor agonists.
    Lund A, Knop FK, Vilsbøll T.
    Expert Opin Emerg Drugs; 2011 Dec 17; 16(4):607-18. PubMed ID: 21905764
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GLP-1 based therapies: differential effects on fasting and postprandial glucose.
    Fineman MS, Cirincione BB, Maggs D, Diamant M.
    Diabetes Obes Metab; 2012 Aug 17; 14(8):675-88. PubMed ID: 22233527
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.
    Maselli DB, Camilleri M.
    Adv Exp Med Biol; 2021 Aug 17; 1307():171-192. PubMed ID: 32077010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.